{{Rsnum
|rsid=2272990
|Gene=RIPK1
|Chromosome=6
|position=3076907
|Orientation=minus
|GMAF=0.152
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RIPK1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 9.7 | 90.3
| HCB | 5.1 | 34.3 | 60.6
| JPT | 8.0 | 34.5 | 57.5
| YRI | 8.2 | 35.4 | 56.5
| ASW | 3.5 | 40.4 | 56.1
| CHB | 5.1 | 34.3 | 60.6
| CHD | 7.3 | 41.3 | 51.4
| GIH | 0.0 | 8.9 | 91.1
| LWK | 0.9 | 29.1 | 70.0
| MEX | 5.2 | 15.5 | 79.3
| MKK | 1.3 | 18.6 | 80.1
| TSI | 0.0 | 10.8 | 89.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=20567846
|Title=RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection
}}

{{PMID Auto
|PMID=19629486
|Title=Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}